NORTHRIDGE, Calif., July 22, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Medicare and Medicare Advantage beneficiaries now have access to the MiniMed Flex™ system with its latest sensor portfolio. This milestone now makes the company's smallest and only app-controlled insulin pump system available to more people living with diabetes. Designed to fit more naturally into everyday life, MiniMed Flex™ helps reduce the daily burden of diabetes management so people can focus more on the moments that matter to them.